抗真菌药物增效剂的研究进展

摘要/Abstract

摘要： 近年来,真菌耐药发生率呈逐年上升趋势, 真菌对氟康唑等氮唑类药物的耐药性最为严重,成为临床抗真菌治疗失败的原因之一。对于耐药真菌的治疗,往往采用加大剂量或联合用药的方法。此外,文献报道了一些植物提取物、小分子化合物能显著增强抗真菌药物对耐药真菌的敏感性,两个药物的协同作用有望成为治疗耐药真菌的新策略。该文结合近几年的研究报道,简要综述了抗真菌药物增效剂的研究进展。

关键词: 真菌耐药, 增效剂, 抗真菌

Abstract: Recently, antifungal resistance showed an increasing trend, especially, the resistance to azole antifungal agents such as fluconazole is the most serious, which attributes to one of the reasons for treatment failure. Increasing dosage of drug or drug combination therapy are common methods to treat drug-resistant fungal. Moreover, it is reported that some plant extracts or small molecules can significantly increase the susceptibility of antifungal drug against resistant isolates. The synergistic effect of two agents is expected to be a new strategy to combat resistant fungal. Herein, we reviewed the advances in research on the sensitizer of antifungal drugs at home and abroad.

Key words: antifungal resistance, synergist, anti-fungal

中图分类号:

R978.5

代黎, 姜远英, 张大志. 抗真菌药物增效剂的研究进展[J]. 中国真菌学杂志, 2013, 8(2): 116-119.

DAI Li, JIANG Yuan-ying, ZHANG Da-zhi. Advances in research on synergists of antifungal drug[J]. Chinese Journal of Mycology, 2013, 8(2): 116-119.

参考文献

[1] Thakur JK, Arthanari H, Yang F, et al. A nuclear receptor-like pathway regulating multidrug resistance in fungi[J]. Nature,2008, 452(7187):604-609.
[2] Denning DW, Park S, Lass-Florl C, et al. High frequency triazole resistance found in non-culturable Aspergillus fumigatus from lungs of patients with chronic fungal disease[J]. Clin Infect Dis, 2011, 52(9):1123-1129.
[3] Bueid A, Howard SJ, Moore CB, et al. Azole antifungal resistance in Aspergillus fumigatus -2008 and 2009[J].J Antimicrob Chemother, 2010,65(10):2116-2118.
[4] 曹永兵,林辉,安毛毛,等.覆盆子用于制备抗真菌药物增效剂产品的用途:中国,201110059300.3.2011-03-11.
[5] 安毛毛,张军东,刘伟,等.诃子用于制备抗真菌药物及抗真菌药物增效剂的用途:中国,201210024802.7.2012-02-06.
[6] 刘伟,安毛毛,慎慧,等. 五倍子用于制备抗真菌药物及抗真菌药物增效剂的用途:中国,201210024801.2.2012-02-06.
[7] 曹永兵,林辉,刘伟,等.月季花用于制备抗真菌药物增效剂产品的用途:中国,201110059346.5.2011-03-11.
[8] Han Y. Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans[J]. Phytomedicine, 2007,14(11):733-738.
[9] Amber K, Aijaz A, Immaculata X, et al. Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole[J]. Phytomedicine,2010,17(12):921-925.
[10] 刘银丽,刘伟,曹永兵,等.茶黄素用作抗真菌药物增效剂的用途:中国,201010157469.8.2010-04-27.
[11] 刘伟,刘银丽,曹永兵,等. 连翘酯苷用作抗真菌药物增效剂的用途:中国,201010157463.0.2010-04-27.
[12] 曹颖瑛,郑泽宇,朱臻宇,等.芒果苷作为抗真菌药物增效剂的用途:中国,201110087412.X.2011-04-08.
[13] 曹颖瑛,朱臻宇,郑泽宇,等. 山奈酚作为抗真菌药物增效剂的用途:中国,201110087126.3.2011-04-08.
[14] 朱臻宇, 曹颖瑛, 郑泽宇,等. 紫草素作为抗真菌药物增效剂的用途:中国,201110078915.0.2011-03-30.
[15] Liu X, Ren B, Gao H, et al. Optimization for the Production of Surfactin with a New Synergistic Antifungal Activity[J]. PLoS ONE, 2012,7(5):e34430.
[16] Venkatesh MP, Rong L. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis[J].J Med Microbiol, 2008,57(9):1113-1121.
[17] Kobayashi T, Kakeya H, Miyazaki T, et al. Synergistic Antifungal Effect of Lactoferrin with Azole Antifungals against Candida albicans and a Proposal for a New Treatment Method for Invasive Candidiasis[J]. Jpn J Infect Dis, 2011, 64(4):292-296.
[18] Jin J,Guo N,Zhang J,et al. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans[J]. Lett Appl Microbiol, 2010,51(3):351-357.
[19] Guo N, Wu XP, Yu L, et al. In vitro and in vivo interactions between fluconazole and allicin against clinical isolates of fluconazole-resistant Candida albicans determined by alternative methods[J]. FEMS Immunol Med Microbiol, 2010,58(2):193-201.
[20] Ahmad A, Khan A, Khan LA, et al. In vitro synergy of eugenol and methyleugenol with fluconazole against clinical Candida isolates[J]. J Med Microbiol, 2010,59(10):1178-1184.
[21] Huang S, Cao YY, Dai BD, et al. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole[J]. Biol Pharm Bull, 2008,31(12):2234-2236.
[22] Mai A, Rotili D, Massa S, et al. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans[J]. Bioorgm Med Chem Lett, 2007, 17(5):1221-1225.
[23] Youngsaye W, Vincent B, Hartland CL, et al. Piperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of Candida albicans clinical isolates[J]. Bioorg Med Chem Lett,2011, 21(18):5502-5505.
[24] Youngsaye W, Dockendorff C, Vincent B, et al. Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles[J]. Bioorg Med Chem Lett, 2012, 22(9):3362-3365.
[25] Guo XL, Leng P, Yang Y, et al. Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump[J]. J Appl Microbiol, 2008,104(3):831-838.
[26] Sun LM, Lv BB, Cheng AX, et al. The effect of plagiochin E alone and in combination with fluconazole on the ergosterol biosynthesis of Candida albicans[J]. Biol Pharm Bull, 2009,32(1):36-40.
[27] Xu Y, Wang Y, Yan L, et al. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans:endogenous ROS augmentation[J]. J Proteome Res, 2009,8(11):5296-5304.
[28] Cao Y, Dai BD, Wang Y, et al. In vitro activity of baicalein against Candida albicans biofilms[J]. Int J Antimicrob Agents, 2008,32(1):73-77.